213 GENES FOUND

? »

Limit search: Premium | Premium (Subcell) | Premium (Cell line)

Page of 5 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ABAT4-aminobutyrate aminotransferaseDisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Tissue enhanced
ABCA1ATP-binding cassette, sub-family A (ABC1), member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ABCC2ATP-binding cassette, sub-family C (CFTR/MRP), member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
ABL1C-abl oncogene 1, non-receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
RAS pathway related proteins
Expressed in all
ACEAngiotensin I converting enzymeCandidate cardiovascular disease genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Group enriched
ACE2Angiotensin I converting enzyme 2Enzymes
FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
ACHEAcetylcholinesterase (Yt blood group)Blood group antigen proteins
Enzymes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
ADAAdenosine deaminaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Tissue enriched
ADH1AAlcohol dehydrogenase 1A (class I), alpha polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Tissue enriched
ADH1BAlcohol dehydrogenase 1B (class I), beta polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Group enriched
ADRB1Adrenoceptor beta 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
AKR1C2Aldo-keto reductase family 1, member C2Disease related genes
Enzymes
FDA approved drug targets
Tissue enhanced
AKR1D1Aldo-keto reductase family 1, member D1Disease related genes
Enzymes
FDA approved drug targets
Tissue enriched
ALADAminolevulinate dehydrataseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
ALOX5Arachidonate 5-lipoxygenaseEnzymes
FDA approved drug targets
Tissue enhanced
AMY2AAmylase, alpha 2A (pancreatic)Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
ANO1Anoctamin 1, calcium activated chloride channelFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
ANXA1Annexin A1Cancer-related genes
FDA approved drug targets
Plasma proteins
Transporters
Expressed in all
AOC3Amine oxidase, copper containing 3Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
APEX1APEX nuclease (multifunctional DNA repair enzyme) 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
ARAndrogen receptorCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Transcription factors
Tissue enhanced
ATIC5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
ATP1A1ATPase, Na+/K+ transporting, alpha 1 polypeptideCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ATP2C1ATPase, Ca++ transporting, type 2C, member 1Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Transporters
Expressed in all
BCRBreakpoint cluster regionCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Expressed in all
BLVRBBiliverdin reductase B (flavin reductase (NADPH))Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
BRAFV-raf murine sarcoma viral oncogene homolog BCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Expressed in all
CA1Carbonic anhydrase IEnzymes
FDA approved drug targets
Plasma proteins
Group enriched
CA2Carbonic anhydrase IIDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Tissue enhanced
CA3Carbonic anhydrase III, muscle specificEnzymes
FDA approved drug targets
Plasma proteins
Tissue enriched
CA4Carbonic anhydrase IVDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1CCalcium channel, voltage-dependent, L type, alpha 1C subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1SCalcium channel, voltage-dependent, L type, alpha 1S subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
CACNA2D1Calcium channel, voltage-dependent, alpha 2/delta subunit 1FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Mixed
CACNA2D2Calcium channel, voltage-dependent, alpha 2/delta subunit 2FDA approved drug targets
Transporters
Tissue enriched
CASRCalcium-sensing receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CATCatalaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
CD44CD44 molecule (Indian blood group)Blood group antigen proteins
Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
CES1Carboxylesterase 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Group enriched
CFTRCystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
CHD1Chromodomain helicase DNA binding protein 1Enzymes
FDA approved drug targets
Expressed in all
CHRNA7Cholinergic receptor, nicotinic, alpha 7 (neuronal)FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Mixed
CKBCreatine kinase, brainCancer-related genes
Candidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
CKMCreatine kinase, muscleCandidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Plasma proteins
Tissue enriched
CKMT2Creatine kinase, mitochondrial 2 (sarcomeric)Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Group enriched
CLCN2Chloride channel, voltage-sensitive 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Mixed
COMTCatechol-O-methyltransferaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Expressed in all
CPS1Carbamoyl-phosphate synthase 1, mitochondrialDisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Group enriched
CPT1ACarnitine palmitoyltransferase 1A (liver)Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted membrane proteins
Expressed in all

Page of 5 | next »